T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy

T-Cell Malignant Neoplasms After Chimeric Ant...

Up next

Metastatic Recurrence Among Adolescents and Young Adults With Cancer

Interview with Ann Brunson, MS, and Theresa H. M. Keegan, PhD, MS, authors of Metastatic Recurrence Among Adolescents and Young Adults With Cancer. Hosted by Vivek Subbiah, MD.

Related Content:

<ul> <li><a class="related-article" href= "https: ...  Show more

Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality

Interview with Yiwen Zhang, PhD, and Edward L. Giovannucci, MD, ScD, authors of Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and Mortality. Hosted by Vivek Subbiah, MD. Related Content: Consistent Adherence to Physical Activity Guidelines ...  Show more

Recommended Episodes

Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfunction
JAMA Otolaryngology–Head & Neck Surgery Author Interviews

Interview with S. A. Reza Nouraei, BChir, PhD, author of Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfunction—The Overwhelmed Vagus Hypothesis. Hosted by Paul C. Bryson, MD, MBA. Related Content: Baroreflex Sensitivity in Patients With Laryngopharyngeal Dysfuncti ...  Show more

Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma
JAMA Otolaryngology–Head & Neck Surgery Author Interviews

Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous ...  Show more

Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab
JAMA Otolaryngology–Head & Neck Surgery Author Interviews

Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related Content: Pathologic Treatment Effect and Survival in HPV-Ne ...  Show more

A natural history of familial platelet disorder with myeloid malignancy; HEXIM1 as an essential transcription regulator in erythropoiesis; residual disease predicts relapse in CML patients
Blood Podcast

In this week's episode we’ll discuss the findings from a natural history study of patients with familial platelet disorder with myeloid malignancy, learn more about the role of HEXIM1 as an essential transcription regulator in human erythropoiesis, and discuss the utility of resi ...  Show more